Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains
- PMID: 10080934
- DOI: 10.1006/bbrc.1999.0377
Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains
Abstract
Recombinant forms of human perlecan domain I were secreted as proteoglycans by stably transfected human 293 cells. A recombinant domain I-only proteoglycan spanned the 95- to 265-kDa region in SDS-PAGE and appeared to be 160 kDa in denaturing gel filtration. Its glycosaminoglycan (GAG) content was approximately 67% heparan sulfate, and its average GAG chain size of 20 kDa suggested that the true molecular mass of the proteoglycan was 90 kDa. Domain I with enhanced green fluorescent protein fused to its C-terminus had an apparent molecular mass of 210-220 kDa and contained approximately 100% heparan sulfate. Its average GAG chain size (also 20 kDa) suggested a true molecular mass of 117 kDa for this proteoglycan. Its sulfate content of 53-77 mol SO2-4 per mole of protein indicated the presence of one sulfate group per 4-7 GAG sugar residues.
Copyright 1999 Academic Press.
Similar articles
-
Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.J Neurosci Res. 1994 Aug 15;38(6):670-86. doi: 10.1002/jnr.490380610. J Neurosci Res. 1994. PMID: 7807583
-
Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.Biochem Biophys Res Commun. 1995 Jun 6;211(1):262-7. doi: 10.1006/bbrc.1995.1805. Biochem Biophys Res Commun. 1995. PMID: 7779094
-
Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.Biochem Biophys Res Commun. 1999 Nov 30;265(3):680-90. doi: 10.1006/bbrc.1999.1714. Biochem Biophys Res Commun. 1999. PMID: 10600481
-
[Biosynthesis of sugar chain backbone in glycosaminoglycan].Tanpakushitsu Kakusan Koso. 1998 Dec;43(16 Suppl):2594-601. Tanpakushitsu Kakusan Koso. 1998. PMID: 9883692 Review. Japanese. No abstract available.
-
The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices.Biochem J. 1994 Sep 15;302 ( Pt 3)(Pt 3):625-39. doi: 10.1042/bj3020625. Biochem J. 1994. PMID: 7945186 Free PMC article. Review. No abstract available.
Cited by
-
A Novel Pathogenic HSPG2 Mutation in Schwartz-Jampel Syndrome.Front Neurol. 2021 Mar 9;12:632336. doi: 10.3389/fneur.2021.632336. eCollection 2021. Front Neurol. 2021. PMID: 33767660 Free PMC article.
-
Modular Proteoglycan Perlecan/HSPG2: Mutations, Phenotypes, and Functions.Genes (Basel). 2018 Nov 16;9(11):556. doi: 10.3390/genes9110556. Genes (Basel). 2018. PMID: 30453502 Free PMC article. Review.
-
Perlecan and tumor angiogenesis.J Histochem Cytochem. 2003 Nov;51(11):1393-410. doi: 10.1177/002215540305101101. J Histochem Cytochem. 2003. PMID: 14566013 Free PMC article. Review.
-
Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia.Int J Mol Sci. 2020 Jan 20;21(2):679. doi: 10.3390/ijms21020679. Int J Mol Sci. 2020. PMID: 31968632 Free PMC article. Review.
-
Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?Molecules. 2015 Mar 5;20(3):4254-76. doi: 10.3390/molecules20034254. Molecules. 2015. PMID: 25751786 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical